1. Home
  2. ZCMD vs XLO Comparison

ZCMD vs XLO Comparison

Compare ZCMD & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZCMD
  • XLO
  • Stock Information
  • Founded
  • ZCMD 2012
  • XLO 2016
  • Country
  • ZCMD China
  • XLO United States
  • Employees
  • ZCMD N/A
  • XLO N/A
  • Industry
  • ZCMD Other Consumer Services
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZCMD Real Estate
  • XLO Health Care
  • Exchange
  • ZCMD Nasdaq
  • XLO Nasdaq
  • Market Cap
  • ZCMD 40.8M
  • XLO 42.1M
  • IPO Year
  • ZCMD 2020
  • XLO 2021
  • Fundamental
  • Price
  • ZCMD $1.48
  • XLO $1.14
  • Analyst Decision
  • ZCMD
  • XLO Buy
  • Analyst Count
  • ZCMD 0
  • XLO 1
  • Target Price
  • ZCMD N/A
  • XLO $4.00
  • AVG Volume (30 Days)
  • ZCMD 11.0K
  • XLO 1.0M
  • Earning Date
  • ZCMD 01-01-0001
  • XLO 11-07-2024
  • Dividend Yield
  • ZCMD N/A
  • XLO N/A
  • EPS Growth
  • ZCMD N/A
  • XLO N/A
  • EPS
  • ZCMD N/A
  • XLO N/A
  • Revenue
  • ZCMD $17,406,104.00
  • XLO $4,620,000.00
  • Revenue This Year
  • ZCMD N/A
  • XLO N/A
  • Revenue Next Year
  • ZCMD N/A
  • XLO $368.76
  • P/E Ratio
  • ZCMD N/A
  • XLO N/A
  • Revenue Growth
  • ZCMD 1.01
  • XLO N/A
  • 52 Week Low
  • ZCMD $1.00
  • XLO $0.50
  • 52 Week High
  • ZCMD $5.10
  • XLO $1.93
  • Technical
  • Relative Strength Index (RSI)
  • ZCMD 43.36
  • XLO 56.51
  • Support Level
  • ZCMD $1.31
  • XLO $0.95
  • Resistance Level
  • ZCMD $1.80
  • XLO $1.22
  • Average True Range (ATR)
  • ZCMD 0.17
  • XLO 0.10
  • MACD
  • ZCMD -0.05
  • XLO 0.01
  • Stochastic Oscillator
  • ZCMD 21.65
  • XLO 74.75

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: